Beneficial Effect of Synbiotic Combination of Limosilactobacillus fermentum FS-10, Lactiplantibacillus plantarum Lp1-IC and Short-Chain Fructooligosaccharides in Colitis Murine Model
Probiotics and Antimicrobial Proteins · 2025-08 · 17 (4) · 1998-2008
DOI: 10.1007/s12602-024-10320-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Probiotics and Antimicrobial Proteins, online erschienen am 10.07.2024. Verfasst von Radha Pujari und 4 weiteren Autor:innen. Beteiligte Einrichtung: Tata Chemicals Limited, Survey No 315, Hissa No 1-14, Paud Rd, Darawali, Pune, Maharashtra, 412111, India. rpujari@tatachemicals.com. Hauptthemen laut MEDLINE: Colitis, Oligosaccharides, Synbiotics, Limosilactobacillus fermentum. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Therapies targeting gut microbiota are being extensively researched for colitis patients. In this study, we have tested the efficacy of indigenously isolated strains Lactiplantibacillus plantarum Lp1-IC and Limosilactobacillus fermentum FS-10 and their combination with short-chain fructooligosaccharides (sc-FOS) in mice models of DSS-induced colitis. For a desired efficacy, a synbiotic should be very meticulously formulated with the right choice of prebiotic and probiotic. Therefore, the ability of lactobacilli to utilize scFOS for growth was first tested by culturing the strains in a specially designed minimal media supplemented with scFOS as carbon source. The bacteria utilized scFOS and produced metabolites such as acetate and lactate. Thereafter, the in vitro anti-inflammatory effect was tested on markers such as TNF-alpha (TNF-α), nitric oxide and IL-10 in human monocyte (THP-1) and mouse macrophage (Raw 264.7) cell lines. The in vivo efficacy was studied in mice model of DSS-induced colitis, and the effect on the systemic and localized inflammatory markers was assessed in serum and colon tissue samples respectively. Administration of DSS elicited predominant clinical signs of weight loss, diarrhoea, faecal occult blood, increase in inflammatory markers and extensive damage of colon tissue. These symptoms were significantly reversed in all the treatment groups; however, the combination of lactobacilli and scFOS performed better than the individual ingredients. The study highlights the potential of the indigenous lactobacilli strains, scFOS and their combination for management of gut inflammation in colitis patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tata Chemicals Limited, Survey No 315, Hissa No 1-14, Paud Rd, Darawali, Pune, Maharashtra, 412111, India. rpujari@tatachemicals.com.
- Tata Chemicals Limited, Survey No 315, Hissa No 1-14, Paud Rd, Darawali, Pune, Maharashtra, 412111, India.
Zitieren
APA
Pujari, R., Jadhav, D., Angal, A., Syed, J., & Dubey, A. K. (2025). Beneficial Effect of Synbiotic Combination of Limosilactobacillus fermentum FS-10, Lactiplantibacillus plantarum Lp1-IC and Short-Chain Fructooligosaccharides in Colitis Murine Model. Probiotics and Antimicrobial Proteins, 17(4), 1998-2008. https://doi.org/10.1007/s12602-024-10320-5
Vancouver
Pujari R, Jadhav D, Angal A, Syed J, Dubey AK. Beneficial Effect of Synbiotic Combination of Limosilactobacillus fermentum FS-10, Lactiplantibacillus plantarum Lp1-IC and Short-Chain Fructooligosaccharides in Colitis Murine Model. Probiotics and Antimicrobial Proteins. 2025;17(4):1998-2008. doi:10.1007/s12602-024-10320-5
BibTeX
@article{Pujari2025,
author = {Pujari, Radha and Jadhav, Deepak and Angal, Ashvini and Syed, Jaserah and Dubey, Ashok Kumar},
title = {Beneficial Effect of Synbiotic Combination of Limosilactobacillus fermentum FS-10, Lactiplantibacillus plantarum Lp1-IC and Short-Chain Fructooligosaccharides in Colitis Murine Model},
journal = {Probiotics and Antimicrobial Proteins},
year = {2025},
volume = {17},
number = {4},
pages = {1998--2008},
doi = {10.1007/s12602-024-10320-5}
}
EUVIMED